
Deepa Belur
Examiner (ID: 2176, Phone: (571)270-3722 , Office: P/2472 )
| Most Active Art Unit | 2472 |
| Art Unit(s) | 2472 |
| Total Applications | 650 |
| Issued Applications | 513 |
| Pending Applications | 62 |
| Abandoned Applications | 96 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19784315
[patent_doc_number] => 20250057994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => LABELED COMPOUNDS AND CALCIUM SENSING RECEPTOR LIGANDS FOR IMAGING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/578434
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18578434
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/578434 | LABELED COMPOUNDS AND CALCIUM SENSING RECEPTOR LIGANDS FOR IMAGING AND USES THEREOF | Jul 10, 2022 | Pending |
Array
(
[id] => 18308112
[patent_doc_number] => 20230112012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => FAP INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/810370
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810370 | FAP INHIBITOR | Jun 30, 2022 | Abandoned |
Array
(
[id] => 18365339
[patent_doc_number] => 20230146930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => 177-LU LABELED ACTIVE SITE INHIBITED FACTOR VII
[patent_app_type] => utility
[patent_app_number] => 17/854532
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854532
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854532 | 177-LU LABELED ACTIVE SITE INHIBITED FACTOR VII | Jun 29, 2022 | Pending |
Array
(
[id] => 18769508
[patent_doc_number] => 20230364278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => RADIOPHARMACEUTICAL PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/850056
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850056 | RADIOPHARMACEUTICAL PRODUCTS | Jun 26, 2022 | Abandoned |
Array
(
[id] => 18019150
[patent_doc_number] => 20220370649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => DUAL MODE RADIOTRACER AND -THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 17/849297
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/849297 | Dual mode radiotracer and -therapeutics | Jun 23, 2022 | Issued |
Array
(
[id] => 18226528
[patent_doc_number] => 20230065522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS OF CANCER DETECTION USING PARPI-FL
[patent_app_type] => utility
[patent_app_number] => 17/846690
[patent_app_country] => US
[patent_app_date] => 2022-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17846690
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/846690 | METHODS OF CANCER DETECTION USING PARPI-FL | Jun 21, 2022 | Abandoned |
Array
(
[id] => 17897001
[patent_doc_number] => 20220306663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => Metal Tricarbonyl Complexes Comprising Substituted Iminodiactic Acid Ligands and Uses as Radioisotope Tracers
[patent_app_type] => utility
[patent_app_number] => 17/836994
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836994 | Metal Tricarbonyl Complexes Comprising Substituted Iminodiactic Acid Ligands and Uses as Radioisotope Tracers | Jun 8, 2022 | Abandoned |
Array
(
[id] => 17881257
[patent_doc_number] => 20220296734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => RADIOPHARMACEUTICAL COMPOSITIONS OF RADIOACTIVE HALOGENATED BENZYLGUANIDINE
[patent_app_type] => utility
[patent_app_number] => 17/831698
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831698 | RADIOPHARMACEUTICAL COMPOSITIONS OF RADIOACTIVE HALOGENATED BENZYLGUANIDINE | Jun 2, 2022 | Abandoned |
Array
(
[id] => 17944439
[patent_doc_number] => 20220331456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => LABELING PRECURSORS WITH SQUARIC ACID COUPLING
[patent_app_type] => utility
[patent_app_number] => 17/745100
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745100 | Labeling precursors with squaric acid coupling | May 15, 2022 | Issued |
Array
(
[id] => 17836522
[patent_doc_number] => 20220273827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => KIT FOR RADIOLABELLING WITH 68GA COMPRISING A METAL INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/742502
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742502 | KIT FOR RADIOLABELLING WITH 68GA COMPRISING A METAL INHIBITOR | May 11, 2022 | Pending |
Array
(
[id] => 19263760
[patent_doc_number] => 20240207457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => CANCER-SPECIFIC POLYPEPTIDE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/288667
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288667 | CANCER-SPECIFIC POLYPEPTIDE AND USE THEREOF | May 9, 2022 | Pending |
Array
(
[id] => 18020546
[patent_doc_number] => 20220372045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => DEUTERATED COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/729881
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729881
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/729881 | Deuterated compounds and imaging agents for imaging huntingtin protein | Apr 25, 2022 | Issued |
Array
(
[id] => 17790619
[patent_doc_number] => 20220249710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/725271
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725271 | BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER | Apr 19, 2022 | Pending |
Array
(
[id] => 17895482
[patent_doc_number] => 20220305144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => RADIOLIGANDS FOR IMAGING THE ID01 ENZYME
[patent_app_type] => utility
[patent_app_number] => 17/722628
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722628
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722628 | RADIOLIGANDS FOR IMAGING THE ID01 ENZYME | Apr 17, 2022 | Abandoned |
Array
(
[id] => 17958722
[patent_doc_number] => 20220339302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/715661
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715661 | ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN | Apr 6, 2022 | Issued |
Array
(
[id] => 19389355
[patent_doc_number] => 20240279225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/554403
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554403
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554403 | COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY | Apr 6, 2022 | Pending |
Array
(
[id] => 19186346
[patent_doc_number] => 20240165259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/285413
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285413
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285413 | BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS | Apr 3, 2022 | Pending |
Array
(
[id] => 17897342
[patent_doc_number] => 20220307004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => Multi-Enzyme Nanoparticle-Assisted Stable Isotope Incorporation Into Small Molecules by Channeling
[patent_app_type] => utility
[patent_app_number] => 17/705781
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705781 | Multi-Enzyme Nanoparticle-Assisted Stable Isotope Incorporation Into Small Molecules by Channeling | Mar 27, 2022 | Pending |
Array
(
[id] => 19263595
[patent_doc_number] => 20240207292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/283391
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -73
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283391
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/283391 | BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS | Mar 23, 2022 | Pending |
Array
(
[id] => 18243463
[patent_doc_number] => 20230075774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/695252
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695252
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695252 | SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS | Mar 14, 2022 | Abandoned |